10x Genomics, Inc. vs Apple Inc.
TXG vs AAPL — side-by-side comparison from reported financials. TXG leads 2, AAPL leads 5 of 7 comparable metrics.
10x Genomics, Inc.
TXG · Technology
$81.05+4.88%Strained
Apple Inc.
AAPL · Technology
$336.11-1.27%Strong
| Metric | TXG | AAPL |
|---|---|---|
| Price | $81.05 | $336.11 |
| Market cap | $10.6B | $4.91T |
| Revenue (TTM) | $617M | $467B |
| Revenue growth | +7.6% | +1.8% |
| Net margin | -12.2% | 27.6% |
| Free cash flow | $121M | $137B |
| Net cash (debt) | — | ($31.6B) |
| 1-year price return | +592.1% | +32.3% |
| P/E | — | 38.1 |
| P/E vs own history (cheap-side %) | — | 7% |
| Dividend yield | — | 0.32% |
| Return on equity | -9% | 137% |
| Altman Z-score | — | 12.84 |
| CV checks passed | 4 of 9 | 11 of 9 |
| Employees | 1,178 | 166,000 |
Full résumé-style profiles: TXG CV · AAPL CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.